Pharma Focus Asia

Repligen

LATEST NEWSRead more...

24

Jul 2024

BeiGene Launches U.S. Biologics Manufacturing and R&D Facility, Advancing Global Expansion to Serve More Patients

BeiGene Ltd a global oncology company has launched its flagship US facility at the Princeton West Innovation Campus in Hopewell NJ This advanced site features cuttingedge biologics

24

Jul 2024

Brenig Therapeutics Raises $65 Million in Series A Funding to Advance Pre-Clinical Pipeline for Parkinson’s Disease

Brenig Therapeutics Inc a trailblazer in neurologyfocused drug development utilizing an AIMLbased discovery platform has successfully completed a million Series A funding round The round was led by New

24

Jul 2024

Flagship Pioneering Introduces Abiologics: Revolutionizing Biotherapeutics with Advanced Capabilities

Flagship Pioneering has introduced Abiologics a new bioplatform company that aims to transform the field of biologics through the development of a novel class of medicines called Synteins

23

Jul 2024

MasterControl Introduces GxPAssist AI to Enhance Life Science Processes

MasterControl a leader in manufacturing and quality management software for regulated industries has introduced GxPAssist AI a suite of generative artificial intelligence AI tools designed to optimize processes for quality and manufacturing professionals These tools aim to enhance efficiency and ens...

23

Jul 2024

FDA Grants Approval for Samsung Bioepis’ EPYSQLI® as a Biosimilar to Soliris®

Samsung Bioepis Co Ltd has received FDA approval for EPYSQLI eculizumabaagh as a biosimilar to Soliris eculizumab EPYSQLI is indicated for treating paroxysmal nocturnal hemoglobinuria PNH to reduce hemolysis and atypical hemolytic uremic syndrome to inhibit complementmediated

22

Jul 2024

Everest Medicines Begins Dosing in China for Global Phase 2b Trial of Zetomipzomib for Lupus Nephritis

Everest Medicines has announced the dosing of the first Chinese patient with zetomipzomib in the global Phase b PALIZADE trial targeting active lupus nephritis Zetomipzomib

Solovpe

press releasesRead more...

24

Jul 2024

Triastek Announces Research Collaboration and Platform Technology License Agreement with BioNTech to Advance 3D Printed Oral RNA Therapeutics

Triastek Inc a global leader in D printing pharmaceuticals today announced that it has entered into a research collaboration and platform technology license agreement with BioNTech SE a next generation

24

Jul 2024

Waters New Rapid Screening-DSC Enables Up to 24x Faster Thermal Stability Testing at Ultra-Low Sample Volumes for Antibody Drugs

Waters Corporation announced today the global release of the TA Instruments Rapid ScreeningDifferential Scanning Calorimeter designed for biopharmaceutical developers

24

Jul 2024

IASO Bio Receives U.S. FDA Approval of Investigational New Drug Application for Equecabtagene Autoleucel for Multiple Sclerosis

IASO Biotechnology a biopharmaceutical company dedicated to discovering developing manufacturing and commercializing innovative cell therapy and antibody products announced that the investigational new drug application for the independently developed

23

Jul 2024

QDX Announces Collaboration with Prelude Therapeutics on Novel Oncology Programs

QDX a computational drug discovery company today announced a collaboration with Prelude Therapeutics a clinicalstage precision oncology company targeting undisclosed previously undrugged

23

Jul 2024

GC Cell and Lukas Announce Strategic Cooperation Agreement to Jointly Tap into the Innovative Cell Therapy including and beyond Korean and Taiwanese Market

GC Cell Corporation and Lukas Biomedical Co Ltd has formally signed an international strategic cooperation agreement GC Cell is a fully integrated pioneer in cell and gene therapy

22

Jul 2024

Biophytis Deploys its Partnership Strategy and Signs Two Contracts with Local Agents in Asia

Biophytis SA a clinicalstage biotechnology company specializing in the development of treatments for agerelated diseases today announces the deployment of its partnership

30 - 01

Jul 2024

30 - 01

Jul 2024

chemical indonesia

jakarta barat, Indonesia

30 - 01

Jul 2024

Inalab 2023

Jakarta Barat, Indonesia

13 - 14

Aug 2024

ADVANCING BUSINESS, TECHNOLOGY AND INNOVATION

Songdo Convensia, Incheon, South Korea

13 - 14

Aug 2024

12 YEARS OF EXCELLENCE: SOUTH KOREA’S BIOLOGICS

Songdo Convensia, Incheon, South Korea

19 - 21

Aug 2024
Hexagon - Expert Insights Webinar
MFA + MMA 2024
4th Annual Cleaning Validation 2024
2nd Annual Pharma Impurity Conclave 2024
CPHI Korea 2024
World Orphan Drug Congress Europe 2024
Thermo Fisher - Drug Discovery and the impact of mAbs

TOP ARTICLES

  • 5

    Neoteric Solvents: A Paradigm Shift in Pharmaceutical Industrial Processes

    Abhinab Goswami

    Pursuing Ph.D., National Institute of Pharmaceutical Education and Research

    Datta Maroti Pawde

    Pursuing Ph.D., National Institute of Pharmaceutical Education and Research

    Syed Nazrin Ruhina Rahman

    Pursuing Ph.D., National Institute of Pharmaceutical Education and Research

    T Raja Sekharan

    Faculty Member, SB College of Pharmacy

    Tamilvanan Shunmugaperumal

    Associate Professor, National Institute of Pharmaceutical Education and Research

    USN Murty

    Director, National Institute of Pharmaceutical Education and Research

KNOWLEDGE BANK

  • Interviews

    Bioquell Asia Pacific,

    Managing Director

    Bioquell Asia Pacific based in Singapore in April to be the regional office for our activities in Asia and Australasia I am responsible for the development of our business throughout the region and for the success and profitability of our activities We provide equipment and services for environmental biodecontamination across the pharmaceutical therapeutic development

EDITORIAL SECTION